The State of Texas Top Legal Officer Takes Legal Action Against Acetaminophen Manufacturers Concerning Autism Spectrum Assertions
The top legal official in Texas Ken Paxton is taking legal action against the producers of acetaminophen, alleging the companies withheld safety concerns that the drug created to children's neurological development.
This legal action follows four weeks after Former President Trump publicized an unproven link between taking acetaminophen - alternatively called acetaminophen - while pregnant and autism in children.
Paxton is suing the pharmaceutical giant, which previously sold the drug, the exclusive pain medication recommended for pregnant women, and the current manufacturer, which now manufacturers it.
In a declaration, he stated they "deceived the public by profiting off of suffering and marketing drugs ignoring the risks."
Kenvue says there is insufficient reliable data tying acetaminophen to autism spectrum disorder.
"These companies misled for generations, knowingly endangering millions to line their pockets," Paxton, a Republican, stated.
The manufacturer said in a statement that it was "very worried by the spread of false claims on the security of acetaminophen and the potential impact that could have on the health of women and children in America."
On its website, Kenvue also mentioned it had "continuously evaluated the applicable studies and there is no credible data that indicates a proven link between taking paracetamol and autism spectrum disorder."
Groups speaking for physicians and health professionals agree.
ACOG has stated acetaminophen - the main ingredient in acetaminophen - is a restricted selection for expectant mothers to address discomfort and elevated temperature, which can pose major wellness concerns if left untreated.
"In more than two decades of studies on the consumption of paracetamol in pregnancy, zero credible investigations has definitively established that the use of paracetamol in any period of gestation causes neurological conditions in young ones," the organization stated.
This legal action cites current declarations from the Trump administration in arguing the medication is potentially dangerous.
Recently, the former president caused concern from health experts when he advised women during pregnancy to "struggle intensely" not to use acetaminophen when sick.
The US Food and Drug Administration then issued a notice that doctors should consider limiting the consumption of Tylenol, while also declaring that "a proven link" between the medication and autism spectrum disorder in young ones has not been proven.
The Health Department head Kennedy, who supervises the FDA, had pledged in spring to initiate "a massive testing and research effort" that would determine the origin of autism in a short period.
But experts advised that discovering a single cause of autism - considered by experts to be the result of a intricate combination of inherited and external influences - would be difficult.
Autism spectrum disorder is a category of permanent neurological difference and disability that influences how persons encounter and engage with the environment, and is identified using physician assessments.
In his legal document, Paxton - a Trump ally who is running for the Senate - asserts the manufacturer and J&J "deliberately disregarded and sought to suppress the research" around paracetamol and autism.
The case aims to force the firms "remove any promotional materials" that states acetaminophen is reliable for pregnant women.
The court case echoes the grievances of a group of parents of children with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the producers of acetaminophen in recently.
The court dismissed the legal action, declaring studies from the family's specialists was not conclusive.